Cocrystal Pharma Inc. (NASDAQ: COCP) is 109.89% higher on its value in year-to-date trading and has touched a low of $0.39 and a high of $3.04 in the current 52-week trading range. The COCP stock was last observed hovering at around $1.36 in the last trading session, with the day’s loss setting it -0.32% off its average median price target of $5.00 for the next 12 months. It is also 79.2% off the consensus price target high of $5.00 offered by 2 analysts, but current levels are 79.2% higher than the price target low of $5.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $1.04, the stock is -45.05% and -41.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.05 million and changing -23.53% at the moment leaves the stock 2.03% off its SMA200. COCP registered -48.51% loss for a year compared to 6-month gain of -21.80%. The firm has a 50-day simple moving average (SMA 50) of $1.8900 and a 200-day simple moving average (SMA200) of $1.2336.
The stock witnessed a -43.78% loss in the last 1 month and extending the period to 3 months gives it a 7.77%, and is -44.68% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.42% over the week and 14.37% over the month.
Cocrystal Pharma Inc. (COCP) has around 11 employees, a market worth around $62.15M and $1.90M in sales. Distance from 52-week low is 169.36% and -65.79% from its 52-week high. The company has generated returns on investments over the last 12 months (-187.60%).
Cocrystal Pharma Inc. (COCP) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Cocrystal Pharma Inc. (COCP) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Cocrystal Pharma Inc. is expected to release its quarterly report on 11/17/2020 and quarterly earnings per share for the current quarter are estimated at -$0.05 with sales reaching $450k over the same period. The EPS is expected to grow by 13.70% this year.
Cocrystal Pharma Inc. (COCP) Top Institutional Holders
30 institutions hold shares in Cocrystal Pharma Inc. (COCP), with 20.01M shares held by insiders accounting for 38.38% while institutional investors hold 27.15% of the company’s shares. The shares outstanding are 52.14M, and float is at 32.23M with Short Float at 0.71%. Institutions hold 16.73% of the Float.
Cocrystal Pharma Inc. (COCP) Insider Activity
A total of 0 insider transactions have happened at Cocrystal Pharma Inc. (COCP) in the last six months, with sales accounting for 0 and purchases happening 0 times.